FDA NDC Directory · JSON-LD · Markdown

Azacitidine

NDC 68001-313 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryNew Drug Application (innovator) · App NDA208216
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsAZACITIDINE (100 mg/1)
Marketing started20170701
Marketing ended20261231
Package count1

External sources

Source: openFDA. Public-domain (CC0).